| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4169248 | The Journal of Pediatrics | 2006 | 9 Pages |
Abstract
The HFA is a versatile short-term in vivo model that may be exploited to predict efficacy of potential anticancer agents in ESFT cells. Tumor markers and pharmacodynamic endpoints may be quantified in the pure population of ESFT cells from within the HFs.
Keywords
Terminal deoxynucleotidyl transferase–mediated dUTP nick-end labelingFACSNCIESFTPVDFETsHFAEWSHFSHollow fiber assayHollow fibersanalysis of varianceANOVATUNELintraperitonealIntravenousfluorescence-activated cell sortingsubcutaneousEwing’s sarcomaNational Cancer InstitutePropidium iodidePolyvinylidene fluoride
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Esther Marie BSc, Michael Charles DSc, BSc, Susan Ann PhD, BSc,